NCT04510220: 9-month Study to Assess the Efficacy of Ofatumumab on Microglia in Patients With Relapsing Forms of Multiple Sclerosis |
|
|
| Recruiting | 3 | 10 | US | Ofatumumab, OMB157, [F-18]PBR06, [18F]PBR06 | Brigham and Women's Hospital, Novartis | Relapsing Multiple Sclerosis | 12/21 | 12/21 | | |